With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. Chalk up another new potential expansion for Lilly as it has ...

Eli Lilly is heading back to its regular Chinese collaborator Innovent Biologics with $350 million in upfront cash to collaborate on new meds for patients with cancer or immune disorders. The ...

Learn how to crochet a cute cake box and lily pad coasters with this easy, beginner-friendly tutorial. #CrochetTutorial #CakeBoxCoasters #BeginnerCrochet Trump slams energy deal between California and ...

Feb 9 (Reuters) - Eli Lilly (LLY.N), opens new tab will buy Orna Therapeutics for up to $2.4 billion in cash, gaining access to a technology that allows patients' own cells to generate therapies ...

Lilly will determine the accounting treatment of this transaction in accordance with Generally Accepted Accounting Principles upon closing, according to the press release statement. Despite trading at ...

Eli Lilly (LLY) has agreed to acquire biotechnology company Orna Therapeutics for up to $2.4B in cash, inclusive of an upfront payment and subsequent payments upon achievement of certain clinical ...

Eli Lilly snaps up Watertown biotech in $2.4 billion deal Orna Therapeutics, which engineers immune cells inside the body, will fold into one of the world’s largest drugmakers.

We love sweaters, but we're over thick, heavy knits, dull hues and frumpy fits — especially since spring is right around the corner. Luckily, Lilly Pulitzer-style sweaters are the antidote to our ...

Sales of Lilly's GLP-1 drugs are surging. Management issued a bullish profit forecast. Lilly's fourth-quarter revenue rose 43% year over year to $19.3 billion. The gains were driven by the biotech's ...

Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash. Eli Lilly on Monday said Orna, which is dedicated to engineering immune ...